Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
0.640
-0.525 (-45.03%)
At close: Jul 1, 2022 4:00 PM
0.628
-0.012 (-1.921%)
After-hours: Jul 1, 2022 7:59 PM EDT

Ratios and Metrics (Annual)

Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Current20212020201920182017201620152014
Market Capitalization
3592511482092164218114
Market Cap Growth
--76.39%69.26%648.84%-78.47%-43.90%-24.66%90.58%-
Enterprise Value
1258213114126713119889
PE Ratio
--0.79-4.84-7.97-1.00-3.25-5.70-7.17-7.10
PS Ratio
0.5114.45335.03------
PB Ratio
1.066.395.093.240.982.533.887.323.17
EV/Sales Ratio
2.1114.86324.24------
Debt / Equity Ratio
4.721.900.33000.290.370.510.41
Debt / EBITDA Ratio
-0.19-0.26-0.3400-0.40-0.54-0.45-0.82
Debt / FCF Ratio
-0.20-0.27-0.3400-0.41-0.67-0.59-1.02
Current Ratio
0.560.827.729.313.812.574.704.894.56
Asset Turnover
0.150.090.01000000
Return on Equity (ROE)
-588.00%-376.30%-72.30%-59.40%-78.90%-79.40%-56.50%-79.60%-113.90%
Return on Assets (ROA)
-176.50%-159.50%-55.40%-55.40%-59.30%-53.20%-40.30%-51.40%-32.50%
Return on Capital (ROIC)
-349.20%-241.10%-80.50%-146.30%-162.40%-169.90%-138.60%-139.70%-85.00%
Earnings Yield
-2390.53%-126.40%-20.66%-12.55%-99.91%-30.78%-17.53%-13.94%-14.08%
FCF Yield
-2255.56%-110.49%-18.99%-10.65%-86.94%-28.13%-14.23%-11.84%-12.79%
Buyback Yield / Dilution
-42.20%-14.63%-71.31%-44.05%-10.91%-9.44%-28.41%-93.22%-22929.43%
Total Shareholder Return
-42.20%-14.63%-71.31%-44.05%-10.91%-9.44%-28.41%-93.22%-22929.43%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).